Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
AUTOR(ES)
Parham, D M
RESUMO
The biopsy specimens of 91 patients between the ages of 38 and 94 with transitional cell carcinoma of the bladder were retrospectively reviewed to determine if the expression of CD15 antigen detected by a monoclonal antibody MC2 was correlated with prognosis. Expression was variable, ranging from strong expression of the antigen by only the superficial cells in well differentiated papillary lesions to weak expression by most cells in solid or invasive tumours. In the invasive component there was a correlation between MC2 expression and tumour type, suggesting that the cell surface carbohydrate detected by MC2 may have a role in cell adhesion. There was no correlation between staining and survival. It is concluded that tumour type, grade, and stage remain the best prognostic indicators of urothelial tumours.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=502576Documentos Relacionados
- Primary choriocarcinoma of the bladder evolving from a transitional cell carcinoma.
- Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.
- Co-localization of GSTP1 and JNK in transitional cell carcinoma of urinary bladder
- Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
- Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.